|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Customers, less allowances of $4,495 and $3,406, respectively | ||||||||||||||||||||
| Other, less allowances of $2,934 and $3,203, respectively | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Non-current assets of discontinued operations | ||||||||||||||||||||
| Total non-current assets of discontinued operations | ||||||||||||||||||||
| Licenses | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangible assets, net of accumulated amortization of $171,773 and $157,208, respectively | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| In service and under construction | ||||||||||||||||||||
| Less: Accumulated depreciation and amortization | ||||||||||||||||||||
| Property, plant and equipment, net of accumulated depreciation and amortization of $4,246,931 and $4,156,666, respectively | ||||||||||||||||||||
| Total in service and under construction | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Other assets and deferred charges | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Customer deposits and deferred revenues | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued taxes | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Short-term operating lease liabilities | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Liabilities held for sale | ||||||||||||||||||||
| Non-current liabilities held for sale | ||||||||||||||||||||
| Non-current liabilities of discontinued operations | ||||||||||||||||||||
| Deferred liabilities and credits | ||||||||||||||||||||
| Deferred income tax liability, net | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Other deferred liabilities and credits | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Noncontrolling interests with redemption features | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| TDS shareholders’ equity | ||||||||||||||||||||
| Series A Common and Common Shares Authorized 290,000 shares (25,000 Series A Common and 265,000 Common Shares) Issued 133,238 shares (7,543 Series A Common and 125,695 Common Shares) and 133,236 shares (7,541 Series A Common and 125,695 Common Shares), respectively Outstanding 115,116 shares (7,543 Series A Common and 107,573 Common Shares) and 113,783 shares (7,541 Series A Common and 106,242 Common Shares), respectively Par Value ($.01 per share) | ||||||||||||||||||||
| Capital in excess of par value | ||||||||||||||||||||
| Preferred Shares, 279,000 shares authorized, par value $0.01 per share, 44,400 shares outstanding (16,800 Series UU and 27,600 Series VV) | ||||||||||||||||||||
| Treasury shares, at cost, 18,122 and 19,453 Common Shares, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total TDS shareholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common Stock, Shares, Outstanding | ||||||||||||||||||||
Loading...